导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.15% | 395/1050 |
| 近一周 | -2.10% | 496/1104 |
| 近一月 | -2.98% | 398/1102 |
| 近一季 | -5.37% | 609/1092 |
| 近半年 | -4.04% | 580/1070 |
| 近一年 | 10.94% | 339/1018 |
| 近两年 | 99.71% | 197/926 |
| 近三年 | 57.23% | 212/833 |
| 成立以来 | 145.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.36% 307/1070 |
17.29% 421/1101 |
- - |
- - |
| 2025 | 40.63% 316/1065 |
6.52% 313/1014 |
5.56% 267/1038 |
21.61% 553/1050 |
2.85% 253/1065 |
| 2024 | 8.27% 326/1011 |
-5.82% 603/960 |
-6.24% 705/983 |
15.02% 227/991 |
6.61% 101/1011 |
| 2023 | -2.89% 155/952 |
10.98% 91/880 |
-4.45% 490/895 |
-6.81% 416/915 |
-1.74% 210/952 |
| 2022 | -17.50% 238/867 |
-12.47% 164/773 |
4.49% 548/806 |
-11.57% 355/845 |
2.00% 325/867 |
| 2021 | 31.98% 62/740 |
3.77% 66/580 |
13.51% 274/659 |
5.39% 123/704 |
6.32% 171/740 |
| 2020 | 42.45% 286/554 |
-0.76% 180/419 |
21.03% 267/466 |
13.78% 166/517 |
4.24% 451/554 |
| 2019 | 26.29% 307/410 |
34.17% 165/1146 |
-10.18% 1073/1228 |
-0.02% 332/390 |
4.81% 344/410 |
| 2018 | - - |
- - |
-14.10% 727/990 |
-9.13% 712/1000 |
-9.79% 281/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 景顺长城量化小盘股票 VS. 东吴新产业精选股票A(580008) |